What is already known about this subject: Repeated cycles of electric stimulation inhibit cutaneous vasoconstriction to noradrenaline, but the mechanism is unknown.
Introduction
Local administration of noradrenaline by iontophoresis produces a dosedependent decrease in skin blood flow in the heated human forearm [1] . Curiously, however, this adrenergic vasoconstrictor response is minimal in forearm skin conditioned by brief, occasional administration of direct anodal current over a 4-10 day period [2] . Investigating this effect might be of clinical interest because peripheral electrical stimulation is useful for pain modulation and appears to assist cutaneous wound healing [3, 4] .
At least three mechanisms could contribute to loss of adrenergic vasoconstriction following electrical stimulation of the skin. First, electrical stimulation induces the antidromic release of vasoactive neuropeptides such as calcitonin gene-related peptide and substance P from sensory nerve terminals [5] .
Release of these neuropeptides from capsaicin-sensitive cutaneous nociceptors initiates a vasodilator response that spreads from the site of stimulation to encompass the terminal distribution of the stimulated neuron [6] . Persistent neurogenic vasodilatation between cycles of electrical stimulation might counter adrenergic vasoconstriction. Second, prostaglandin synthesis under the contact electrodes used for iontophoresis contributes to current-induced vasodilatation [7, 8] . This vasodilator response might also mask adrenergic vasoconstriction. Third, the electrical stimulus could provoke the local release of noradrenaline from sympathetic nerve terminals.
Although this would initially oppose neurogenic vasodilatation to the electrical current [9] , repeated electrically-evoked release of noradrenaline might down-regulate cutaneous vascular adrenoceptors [10] , thereby inhibiting adrenergic vasoconstriction.
The aim of the present study was to examine the effect of the conditioning pretreatment on vasoconstriction to noradrenaline and vasopressin, and on axon-reflex 5 vasodilatation to noradrenaline and histamine in the skin of the human forearm.
Selective attenuation of adrenergic responses would support the hypothesis that repetitive electrical stimulation promotes the desensitization of cutaneous adrenoceptors. Introduction of histamine into the skin of the forearm provokes a flare, mediated by H 1 receptors, that spreads well beyond the site of stimulation [11] . A flare that is greater than the response to electrical stimulation alone, and that is inhibited by topically-applied local anaesthetic agent, also develops after the iontophoresis of noradrenaline in the human forearm [12] . The mechanism of this vasodilator response is uncertain, but may involve direct stimulation of adrenergic receptors in the skin. If so, electrically-provoked desensitization of these adrenergic receptors should attenuate the flare to noradrenaline but should not affect the flare provoked by histamine. To investigate these hypotheses, vascular responses to vasopressin, histamine and noradrenaline were examined at pre-treated and untreated sites in the human forearm.
Method Subjects
The sample consisted of ten healthy volunteers (three men and seven women aged between 21 and 38 years) who were not taking prescription medication (apart from the oral contraceptive) for any medical condition. They each provided informed consent for the procedures, which were approved by the Murdoch University Human Research Ethics Committee.
Overview of the procedures
After ten days of pre-treatment at three sites on the forearm, subjects participated in two experiments at 1-2 day intervals. The pre-treatment regime was maintained at the three experimental sites between the experiments. In each of the 6 experiments described below, drugs were introduced into pre-treated and untreated skin by iontophoresis, and effects of the drug on skin blood flow were evaluated. Different iontophoresis capsules were used for each drug solution to prevent any inadvertent mixing of the drugs.
Pre-treatment
A perspex capsule with an internal chamber diameter of 20 mm was attached with an adhesive washer to a site on the dorsal aspect of the left or right forearm, and a 3 cm x 5 cm silver plate coated with conductive gel that acted as a cathode was attached to the upper arm. To ensure that the capsule adhered firmly and that good electrical contact was made, the site was shaved, if necessary, and cleaned with an isopropyl alcohol swab. Care was taken not to touch the skin with the razor while the hair was being removed. The chamber was filled with a conducting medium (0.9% saline) and the skin underneath the chamber was stimulated with direct anodal current of 0.2 mA for two minutes. The perimeter of the capsule was marked with indelible ink so that the capsule could be repositioned accurately when the electrical stimulation was repeated. The same procedure was carried out at two additional sites on the same forearm, separated from the other sites by at least 10 cm. Each site was stimulated twice per day for the next ten days. This pre-treatment sequence inhibits vasoconstrictor responses to noradrenaline administered by iontophoresis in the skin of the human forearm [2] . Experiment 2: vasoconstriction to noradrenaline and vasopressin Noradrenaline (0.5 mM) was introduced into one of the three pre-treated sites (selected at random) from an iontophoresis capsule with a chamber diameter of 10 mm using a 50 µA direct current for 60 seconds. Noradrenaline was also introduced into an untreated site 3-5 cm away on the forearm at the same current intensity and duration. The dose of noradrenaline delivered by this current was expected to produce minor vasoconstriction at the site of administration [1] . Vasopressin was introduced into the second pre-treated site and an untreated site nearby. The same stimulus parameters were used for noradrenaline and vasopressin, to ensure that any nonspecific effects of iontophoresis on skin blood flow were similar at both sites. The electric current was also passed through a conducting medium (0.9% saline) at the third pre-treated site and another untreated site nearby in the same forearm, to delineate any nonspecific effect of iontophoresis. Laser Doppler flow probe holders were then attached over the sites of iontophoresis and over a reference site several cm away from the other sites with adhesive washers.
To ensure that normal endogenous constrictive influences on cutaneous vessels were minimal, the forearm was immersed in 42 o C water for ten minutes before vascular measures commenced. Skin blood flow increases for around 35 minutes in the heated forearm before reaching an upper limit [13] . However, only 10-15 minutes of heating was employed in the present study because laser Doppler measures of flow appear to saturate before skin blood flow peaks [13] . In forearm skin heated to 42 In the group as a whole, vasoconstriction to vasopressin was similar at the pretreated and untreated sites ( Figures 2B and 2E ). There was some individual variation significant; in addition, the median response was 55% (I.R. 79% to 36%) below reference levels in untreated skin compared with 41% below reference levels (I.R. 80% below to 28% above reference levels) in pre-treated skin, Wilcoxon's Z = 0.73, not significant].
In contrast to vasopressin, adrenergic vasoconstriction developed at the untreated site in all but one subject, and was significantly greater in untreated than pre-treated skin (for arbitrary units of flow, Wilcoxon's Z = 2.31, p<0.05, Figure 2C; for percent change from reference sites, Wilcoxon's Z = 2.31, p<0.05, Figure 2E ).
Discussion
Pre-treatment of the skin of the forearm with brief cycles of electrical stimulation over a ten-day period produced two interesting effects. First, the pretreatment blocked vasoconstriction to noradrenaline, thus confirming previous findings [2] , but did not block vasoconstriction to vasopressin. Second, the pretreatment reduced axon-reflex vasodilatation to noradrenaline whereas axon-reflex vasodilatation to histamine remained largely unchanged. Drummond and Lipnicki [2] reported that skin blood flow in the heated forearm was 58% lower than blood flow at reference sites after the iontophoresis of noradrenaline; however, flow at a site pre-treated with brief cycles of electrical stimulation was only 7% lower than flow at reference sites. After similar procedures in the present experiment, the median decrease in blood flow was 53% below reference levels at the untreated site compared with an increase of 1% at the pretreated site. Thus, the conditioning pre-treatment blocked adrenergic vasoconstriction in both studies. The vasoconstrictive response apparently peaked at the untreated site because doubling the dose produced no further vasoconstriction. Although adrenergic vasoconstriction was minimal at the pre-treated site, vasoconstriction to vasopressin was unaffected by the pre-treatment. Thus, the conditioning pre-treatment appeared to evoke a specific decrease in the vascular response to noradrenaline.
Iontophoresis of noradrenaline triggered vasodilatation in nearby skin, both in the present and a previous study [12] . Topical application of local anaesthetic agent blocks the flare to noradrenaline, consistent with neural mediation of this response [12] . Houghton et al. [14] reported recently that low-dose noradrenaline infusion via intradermal microdialysis fibres facilitated axon-reflex vasodilatation to gradual local heating of the skin; conversely, adrenergic blockade inhibited axon-reflex vasodilatation to direct heating. However, in the absence of iontophoretic currents or local heating, intradermal administration of noradrenaline through microdialysis fibres does not induce axon-reflex vasodilatation [15] . One potential explanation for these findings is that an axon reflex to direct heat or iontophoretic currents disrupts protective barriers that normally shield adrenoceptors from adrenergic agents in the extracellular fluid [16, 17] . Excitation of the unshielded adrenoceptors might then facilitate the axon reflex initiated by heating the skin or by iontophoretic currents.
The conditioning pre-treatment inhibited the flare to noradrenaline, consistent with desensitization of adrenergic receptors on the afferent limb of the axon reflex. In contrast to noradrenaline, responses to histamine in pre-treated skin were similar to (although less variable than) responses in untreated skin, at least when expressed as percent change from baseline. This decrease in variability may have been due to depletion of neuropeptide stores in sensory nerve fibres or down-regulation of vascular responses to these neuropeptides. The alternate possibility, that the pretreatment disrupted drug delivery into the skin, seems unlikely because the vasoconstrictor response to vasopressin was unaffected by the pre-treatment. In the short-term, passage of an electric current through a saline solution enhances 13 vasoconstriction to adrenergic agents administered subsequently by iontophoresis [18] , possibly because an axon reflex initiated by the iontophoretic current assists the entry of pharmacological agents into the skin.
Taken together, the findings suggest that repeated cycles of electrical stimulation down-regulate neural and vascular responses to noradrenaline. Periarterial nerve stimulation triggers the release of noradrenaline from adrenergic nerves and calcitonin gene-related peptide from capsaicin-sensitive sensory nerves [19, 20] .
Exposure to a high concentration of adrenergic agonists desensitizes vascular smooth muscle to these agents by decreasing the number of post-junctional α-adrenergic binding sites [10] . In the present study, desensitization may have spilt over to adrenergic receptors that directly or indirectly excite the sensory afferents that mediate axon reflexes. Evidence from several sources suggests that α-adrenoceptors are normally present in the cell bodies of primary afferent neurons. For example, messenger RNA for α 1 -adrenoceptors was detected in the superficial dorsal horn and dorsal root ganglia of rats [21] . In addition, noradrenaline and the α 1 -adrenoceptor agonist phenylephrine increased the excitability of cultured dorsal root ganglion neurons [22, 23] . Further investigation is required to determine whether noradrenaline binds directly to neural adrenoceptors or stimulates sensory nerves indirectly by releasing nociceptive mediators such as prostaglandins or nitric oxide [24, 25] .
Clinical implications
Noradrenaline increases sensitivity to heat, particularly in inflamed skin [16, 26] . Conversely, the conditioning pre-treatment inhibits thermal hyperalgesia induced by the topical application of capsaicin, and reduces adrenergic hyperalgesia in heatsensitized skin [2] . Thus, the conditioning pre-treatment could potentially be 14 beneficial for pain control in patients with painful neuropathies associated with heightened adrenergic sensitivity [27, 28] .
Electrical stimulation may also accelerate the healing of chronic superficial wounds, in part by increasing blood flow and tissue oxygenation around the site of injury [4] . A reduction in adrenergic vasoconstrictor tone following brief cycles of electrical stimulation could facilitate the healing of ischaemic wounds. The persistence of axon-reflex vasodilatation to histamine, despite a reduction in adrenergic sensitivity, is particularly encouraging, because in the presence of an adequate blood supply neurogenic inflammation may assist normal healing processes [29] .
Limitations and directions for future research
Vasodilator responses to histamine and noradrenaline were extremely variable, possibly because responses were expressed in relation to low levels of blood flow at baseline. In future studies, standardizing responses against an estimate of maximal flow at each site (induced by sustained local heating or sodium nitroprusside administration) [30] [31] [32] might reduce variability and permit more precise analysis of treatment effects. Delineation of dose-response relationships would also help to clarify treatment effects.
Finally, the sample was small and consisted of healthy young adults, some of whom were taking oral contraceptives. Effects of age, gender, cardiovascular disease, inflammation, peripheral neuropathy and drug treatments on electrically-evoked release of noradrenaline in the skin, and on desensitization of responses to noradrenaline, require further study. Vasoconstrictor responses to vasopressin and noradrenaline
